Drug Discovery

scientist holding tube with drug
Dr. Peterson said the new compound library received from the alliance with Aeterna Zentaris gives MUSC a huge advantage in creating new drugs.

Drug Discovery at MUSC brings together outstanding basic science and clinical researchers with pharmaceutical and biotechnology industries to develop innovative therapies and medicines. The portfolio includes therapies and medicines for the treatment of cancer, fibrotic and inflammatory diseases and neurological disorders. Broader initiatives include creating strategies for drug discovery and development that will support industry partnership and collaboration opportunities.

Featured Centers & Institute:

Related SmartState® Centers:

  • Cancer Drug Discovery
  • Cancer Stem Cell Biology and Therapy
  • Clinical Effectiveness and Patient Safety
  • Gastrointestinal Cancer Diagnostics
  • Lipidomics, Pathobiology and Therapy
  • Medication Safety and Efficacy
  • Proteomics
  • Tobacco-related Malignancy
  • Translational Cancer Therapeutics